GILD needs to hostile and buy a winner while biotechs are selling for a discount.
I'm in those biotechs as well. Have big stake in many including BMRN. The focus on the board on P has been ridiculous. Bitesr posting at 1:00 am in the morning, tells me he is divorced like Leo says. No women would be married to him that is oblivious from his posts.
The content of those article's provide more insight and credible content than what I've seen so far on these threads, which is truly speculation. Bitesr is a short, and there are a lot of fools playing unwittingly along his same mantra posts that he repeats over and over again.
Not in CS's PT model either. Green today. When Juno settles out that should be a buy.
Well I've made millions, so if that makes me a failure thats ok with me. I think MDVN is pricing themselves out of a buyer. Tell me why hasn't AMGN made a bid?
The molecule was modified by CTIX to increase the alkalinity. Did you read the patent CTIX is using? Nice headline Rayonman.
Bitesr has probably lost it, livid that Leo got out of bed and is not using a catheter. He probably ranting, "Nooooooooooooooooooooooooo, Leo Noooooooooooooooooooooooo....what are you doing? Noooooooooooooooo". LOL.
It was already published by BMRN they were doing this so they could meet with EU regulators first on a patient that already had elevated ALT levels. They should have publized it more, because all they did was update the trial site based on what they said they were going to do several weeks ago. It's a non-event that has turned in an event based on poor PR. I bought a 1000 more shares on the dip. Take advantage while the BS sale is ongoing.
Interesting , it's best he is on your side not against. Must be an article coming out from The Street, or Jim Cramer will mention as a spec play. AFs rule on investing in small bios has an over 90% accuracy rate for spotty failures. So he must think CTIX is a winner.
Than Ortezla, no doubt when you factor in the safety profile. The higher dosages in the next trial will completely blow away the competition. From the looks of the PH-II Trial higher dosing results. Then there is K. Results should be soon.
Odd that its rumored to be MRK. I could see $132 as the starting prices probably 20% where it will end up. Since the rumor is MRK, I almost believe it.